Rennova Health Profit Margin

Rennova Health (RNVAW) currently reports a profit margin of -41.36% as of December 2023. That compares with -25.26% in the prior-year period — down 63.7% year over year. That is below the sector sector average of 13.23%. Use the charts on this page to explore Rennova Health's profit margin history and peer comparisons.

Rennova Health's profit margin decreased from -25.26% to -41.36% — a 63.7% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rennova Health's profit margin of -41.36% is lower than the its sector sector average of 13.23%. That is roughly 412.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Rennova Health's current -41.36% should be judged against industry norms (sector average: 13.23%) and against RNVAW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -41.36%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for Rennova Health, and consider following RNVAW for alerts when major investors trade the stock.